US biotech firm Moderna said Monday it was seeking conditional approval for use of its Covid-19 vaccine on teens in the European Union and Canada, in a boost for inoculation campaigns as the summer begins.
The firm said it also plans to file for emergency approval with the Food and Drug Administration in the United States, where the Pfizer/BioNTech jab is already being administered to adolescents age 12 and up.
“We are pleased to announce that we have submitted for conditional marketing approval of our Covid-19 vaccine with the European Medicines Agency for use in adolescents in the European Union,” Moderna CEO Stephane Bancel said.
“We are encouraged that the Moderna Covid-19 vaccine was highly effective at preventing Covid-19 and SARS-CoV-2 infection in adolescents,” he said in a statement.
“We have filed for authorization with Health Canada and we will file for an Emergency Use Authorization with the US FDA and regulatory agencies around the world for this important younger…
